Generic Name and Formulations:
Chlophedianol HCl 12.5mg, pseudoephedrine HCl 30mg; per 5mL; syrup; alcohol-, dye-, gluten-, sugar-free; grape flavor.
Centrix Pharmaceutical, Inc.
Indications for CLOFERA:
Nonproductive cough, nasal congestion.
10mL every 6–8 hours; max 4 doses/24 hours.
<6yrs: not recommended. 6–11yrs: 5mL every 6–8 hours; max 4 doses/24 hours.
During or within 14 days of MAOIs.
Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized.
Antitussive + sympathomimetic.
Nervousness, dizziness, insomnia.
Endocrinology Advisor Articles
- AUA: New Guidelines for Diagnosis, Management of Testosterone Deficiency
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Canagliflozin May Improve Renal Outcomes in Patients With Type 2 Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- ADA Updates Guidelines for Cardiovascular Risk Management in Diabetes
- Diabetes Treatments
- ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes
- Accuracy of Novel Implantable Continuous Glucose Monitoring Device Assessed
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Risk Factors for Cardiovascular Disease in Youth With Type 1 Diabetes
- USPSTF Issues Recommendation for Vitamin D, Calcium Supplementation for Fracture Prevention
- Obesity Risk in Infants Born to Women With Diabetes
- Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Oxyntomodulin Augments Glucose Homeostasis